Loading...
By Kelly Young
Edited by Jaye Elizabeth Hefner, MD
High-intensity surveillance for patients who've had colorectal adenomas removed at screening is associated with moderate clinical benefits while still being cost-effective, suggests a modeling study in the Annals of Internal Medicine.
Researchers assessed various screening strategies in patients who had low-risk adenomas (1 to 2 small adenomas) or high-risk adenomas (3 to 10 small adenomas or at least 1 large adenoma) removed after screening.
Compared with nonscreening, returning to regular colonoscopic screening lowered lifetime colorectal cancer risk by 39%, low-intensity surveillance (10 years after low-risk adenoma removal, 5 years after high-risk removal) lowered risk by roughly 47%, and high-intensity surveillance (5 years after low-risk removal, 3 years after high-risk) reduced it by approximately 55%.
The authors conclude: "Our results support the current U.S. recommendations for 3-year surveillance after [high-risk adenoma] removal and suggest that 5-year surveillance after [low-risk adenoma] removal is reasonable."
Comment
LINK(S):
Annals of Internal Medicine article (Free abstract)
Annals of Internal Medicine editorial (Subscription required)
Background: NEJM Journal Watch Gastroenterology coverage comparing colorectal cancer screening modalities (Your NEJM Journal Watch registration required)